Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution
Purpose This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution. Methods Between June 1999 and December 2007, 337 patients with multicentric breast cancer and a clinically negative axill...
Gespeichert in:
| Veröffentlicht in: | Annals of surgical oncology 2011-10, Vol.18 (10), p.2879-2884 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2884 |
|---|---|
| container_issue | 10 |
| container_start_page | 2879 |
| container_title | Annals of surgical oncology |
| container_volume | 18 |
| creator | Gentilini, Oreste Veronesi, Paolo Botteri, Edoardo Soggiu, Fiammetta Trifirò, Giuseppe Lissidini, Germana Galimberti, Viviana Musmeci, Simona Raviele, Paola Rafaniello Toesca, Antonio Ratini, Silvia Castillo, Andres Del Colleoni, Marco Talakhadze, Nina Rotmensz, Nicole Viale, Giuseppe Veronesi, Umberto Luini, Alberto |
| description | Purpose
This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution.
Methods
Between June 1999 and December 2007, 337 patients with multicentric breast cancer and a clinically negative axilla underwent lymphatic mapping by a single periareolar/peritumoral (
n
= 306) or a double peritumoral or subdermal injection (
n
= 31) of
99m
Tc-HSA nanocolloids. The sentinel lymph node (SLN) was evaluated by intraoperative frozen section and axillary dissection was performed only in cases of positive SLNB.
Results
The median age of the patients was 48 (range, 22–81) years. The mean number of hot spots identified was 1.4 in the whole series, 1.3 in patients who received a single injection, and 1.7 in those who received a double injection (
P
|
| doi_str_mv | 10.1245/s10434-011-1694-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_888706605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2449661071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-6a6887d04d6254ac2cf45567c875d26c0dd3c560b49222e9db390866efa7c0c13</originalsourceid><addsrcrecordid>eNp1kMlOwzAURS0EgjJ8ABtksQ94TsKOVgyVCkgUFqws13kpRq1T7ATUv8dVGFasbL137n3SQeiYkjPKhDyPlAguMkJpRlUpMr6FBlSmiVAF3U5_ooqsZEruof0Y3wihOSdyF-0xKvJSlXSAPqfgW-dhgSfr5eoV3zcV4KFrVnGNncd33aJ1NiHBWTwMYGKLR8ZbCBf42n1A9gIm4EeIiYubgMETE-aApxAcRFyHZplmU-fnC8BjH1vXdq1r_CHaqc0iwtH3e4Cer6-eRrfZ5OFmPLqcZJbzos2UUUWRV0RUiklhLLO1kFLltshlxZQlVcWtVGQmSsYYlNWMl6RQCmqTW2IpP0Cnfe8qNO8dxFa_NV3w6aQuUjNRisgE0R6yoYkxQK1XwS1NWGtK9Ma07k3rZFpvTGueMiffxd1sCdVv4kdtAlgPxLTycwh_l_9v_QIeCIiJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>888706605</pqid></control><display><type>article</type><title>Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Gentilini, Oreste ; Veronesi, Paolo ; Botteri, Edoardo ; Soggiu, Fiammetta ; Trifirò, Giuseppe ; Lissidini, Germana ; Galimberti, Viviana ; Musmeci, Simona ; Raviele, Paola Rafaniello ; Toesca, Antonio ; Ratini, Silvia ; Castillo, Andres Del ; Colleoni, Marco ; Talakhadze, Nina ; Rotmensz, Nicole ; Viale, Giuseppe ; Veronesi, Umberto ; Luini, Alberto</creator><creatorcontrib>Gentilini, Oreste ; Veronesi, Paolo ; Botteri, Edoardo ; Soggiu, Fiammetta ; Trifirò, Giuseppe ; Lissidini, Germana ; Galimberti, Viviana ; Musmeci, Simona ; Raviele, Paola Rafaniello ; Toesca, Antonio ; Ratini, Silvia ; Castillo, Andres Del ; Colleoni, Marco ; Talakhadze, Nina ; Rotmensz, Nicole ; Viale, Giuseppe ; Veronesi, Umberto ; Luini, Alberto</creatorcontrib><description>Purpose
This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution.
Methods
Between June 1999 and December 2007, 337 patients with multicentric breast cancer and a clinically negative axilla underwent lymphatic mapping by a single periareolar/peritumoral (
n
= 306) or a double peritumoral or subdermal injection (
n
= 31) of
99m
Tc-HSA nanocolloids. The sentinel lymph node (SLN) was evaluated by intraoperative frozen section and axillary dissection was performed only in cases of positive SLNB.
Results
The median age of the patients was 48 (range, 22–81) years. The mean number of hot spots identified was 1.4 in the whole series, 1.3 in patients who received a single injection, and 1.7 in those who received a double injection (
P
< 0.001). The mean number of removed SLNs was 1.7 (median, 1; range, 1–7) with an identification rate of 100%. A total of 138 patients with negative SLNB (
n
= 134) or isolated tumor cells in the SLN (
n
= 4) did not receive completion axillary lymph node dissection (CALND). In these latter patients, a total of 27 events (19.5%) occurred with 3 patients (2.2%) developing axillary recurrences after a median follow-up of 5 years (range, 17–134 months).
Conclusions
Axillary lymph node reappearance was infrequent among patients with multicentric breast cancer, having negative SLNB and no CALND. We recommend SLNB as the standard procedure for nodal staging in patients with multicentric breast cancer and a clinically negative axilla.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-011-1694-3</identifier><identifier>PMID: 21479691</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Axilla ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Breast Oncology ; Carcinoma, Ductal, Breast - mortality ; Carcinoma, Ductal, Breast - secondary ; Carcinoma, Ductal, Breast - surgery ; Carcinoma, Lobular - mortality ; Carcinoma, Lobular - secondary ; Carcinoma, Lobular - surgery ; Female ; Follow-Up Studies ; Humans ; Medicine ; Medicine & Public Health ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - surgery ; Neoplasm Staging ; Oncology ; Prognosis ; Retrospective Studies ; Sentinel Lymph Node Biopsy ; Surgery ; Surgical Oncology ; Survival Rate ; Young Adult</subject><ispartof>Annals of surgical oncology, 2011-10, Vol.18 (10), p.2879-2884</ispartof><rights>Society of Surgical Oncology 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c338t-6a6887d04d6254ac2cf45567c875d26c0dd3c560b49222e9db390866efa7c0c13</citedby><cites>FETCH-LOGICAL-c338t-6a6887d04d6254ac2cf45567c875d26c0dd3c560b49222e9db390866efa7c0c13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-011-1694-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-011-1694-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21479691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gentilini, Oreste</creatorcontrib><creatorcontrib>Veronesi, Paolo</creatorcontrib><creatorcontrib>Botteri, Edoardo</creatorcontrib><creatorcontrib>Soggiu, Fiammetta</creatorcontrib><creatorcontrib>Trifirò, Giuseppe</creatorcontrib><creatorcontrib>Lissidini, Germana</creatorcontrib><creatorcontrib>Galimberti, Viviana</creatorcontrib><creatorcontrib>Musmeci, Simona</creatorcontrib><creatorcontrib>Raviele, Paola Rafaniello</creatorcontrib><creatorcontrib>Toesca, Antonio</creatorcontrib><creatorcontrib>Ratini, Silvia</creatorcontrib><creatorcontrib>Castillo, Andres Del</creatorcontrib><creatorcontrib>Colleoni, Marco</creatorcontrib><creatorcontrib>Talakhadze, Nina</creatorcontrib><creatorcontrib>Rotmensz, Nicole</creatorcontrib><creatorcontrib>Viale, Giuseppe</creatorcontrib><creatorcontrib>Veronesi, Umberto</creatorcontrib><creatorcontrib>Luini, Alberto</creatorcontrib><title>Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>Purpose
This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution.
Methods
Between June 1999 and December 2007, 337 patients with multicentric breast cancer and a clinically negative axilla underwent lymphatic mapping by a single periareolar/peritumoral (
n
= 306) or a double peritumoral or subdermal injection (
n
= 31) of
99m
Tc-HSA nanocolloids. The sentinel lymph node (SLN) was evaluated by intraoperative frozen section and axillary dissection was performed only in cases of positive SLNB.
Results
The median age of the patients was 48 (range, 22–81) years. The mean number of hot spots identified was 1.4 in the whole series, 1.3 in patients who received a single injection, and 1.7 in those who received a double injection (
P
< 0.001). The mean number of removed SLNs was 1.7 (median, 1; range, 1–7) with an identification rate of 100%. A total of 138 patients with negative SLNB (
n
= 134) or isolated tumor cells in the SLN (
n
= 4) did not receive completion axillary lymph node dissection (CALND). In these latter patients, a total of 27 events (19.5%) occurred with 3 patients (2.2%) developing axillary recurrences after a median follow-up of 5 years (range, 17–134 months).
Conclusions
Axillary lymph node reappearance was infrequent among patients with multicentric breast cancer, having negative SLNB and no CALND. We recommend SLNB as the standard procedure for nodal staging in patients with multicentric breast cancer and a clinically negative axilla.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Axilla</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Breast Oncology</subject><subject>Carcinoma, Ductal, Breast - mortality</subject><subject>Carcinoma, Ductal, Breast - secondary</subject><subject>Carcinoma, Ductal, Breast - surgery</subject><subject>Carcinoma, Lobular - mortality</subject><subject>Carcinoma, Lobular - secondary</subject><subject>Carcinoma, Lobular - surgery</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Neoplasm Staging</subject><subject>Oncology</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Sentinel Lymph Node Biopsy</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><subject>Young Adult</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kMlOwzAURS0EgjJ8ABtksQ94TsKOVgyVCkgUFqws13kpRq1T7ATUv8dVGFasbL137n3SQeiYkjPKhDyPlAguMkJpRlUpMr6FBlSmiVAF3U5_ooqsZEruof0Y3wihOSdyF-0xKvJSlXSAPqfgW-dhgSfr5eoV3zcV4KFrVnGNncd33aJ1NiHBWTwMYGKLR8ZbCBf42n1A9gIm4EeIiYubgMETE-aApxAcRFyHZplmU-fnC8BjH1vXdq1r_CHaqc0iwtH3e4Cer6-eRrfZ5OFmPLqcZJbzos2UUUWRV0RUiklhLLO1kFLltshlxZQlVcWtVGQmSsYYlNWMl6RQCmqTW2IpP0Cnfe8qNO8dxFa_NV3w6aQuUjNRisgE0R6yoYkxQK1XwS1NWGtK9Ma07k3rZFpvTGueMiffxd1sCdVv4kdtAlgPxLTycwh_l_9v_QIeCIiJ</recordid><startdate>20111001</startdate><enddate>20111001</enddate><creator>Gentilini, Oreste</creator><creator>Veronesi, Paolo</creator><creator>Botteri, Edoardo</creator><creator>Soggiu, Fiammetta</creator><creator>Trifirò, Giuseppe</creator><creator>Lissidini, Germana</creator><creator>Galimberti, Viviana</creator><creator>Musmeci, Simona</creator><creator>Raviele, Paola Rafaniello</creator><creator>Toesca, Antonio</creator><creator>Ratini, Silvia</creator><creator>Castillo, Andres Del</creator><creator>Colleoni, Marco</creator><creator>Talakhadze, Nina</creator><creator>Rotmensz, Nicole</creator><creator>Viale, Giuseppe</creator><creator>Veronesi, Umberto</creator><creator>Luini, Alberto</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20111001</creationdate><title>Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution</title><author>Gentilini, Oreste ; Veronesi, Paolo ; Botteri, Edoardo ; Soggiu, Fiammetta ; Trifirò, Giuseppe ; Lissidini, Germana ; Galimberti, Viviana ; Musmeci, Simona ; Raviele, Paola Rafaniello ; Toesca, Antonio ; Ratini, Silvia ; Castillo, Andres Del ; Colleoni, Marco ; Talakhadze, Nina ; Rotmensz, Nicole ; Viale, Giuseppe ; Veronesi, Umberto ; Luini, Alberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-6a6887d04d6254ac2cf45567c875d26c0dd3c560b49222e9db390866efa7c0c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Axilla</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Breast Oncology</topic><topic>Carcinoma, Ductal, Breast - mortality</topic><topic>Carcinoma, Ductal, Breast - secondary</topic><topic>Carcinoma, Ductal, Breast - surgery</topic><topic>Carcinoma, Lobular - mortality</topic><topic>Carcinoma, Lobular - secondary</topic><topic>Carcinoma, Lobular - surgery</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Neoplasm Staging</topic><topic>Oncology</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Sentinel Lymph Node Biopsy</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gentilini, Oreste</creatorcontrib><creatorcontrib>Veronesi, Paolo</creatorcontrib><creatorcontrib>Botteri, Edoardo</creatorcontrib><creatorcontrib>Soggiu, Fiammetta</creatorcontrib><creatorcontrib>Trifirò, Giuseppe</creatorcontrib><creatorcontrib>Lissidini, Germana</creatorcontrib><creatorcontrib>Galimberti, Viviana</creatorcontrib><creatorcontrib>Musmeci, Simona</creatorcontrib><creatorcontrib>Raviele, Paola Rafaniello</creatorcontrib><creatorcontrib>Toesca, Antonio</creatorcontrib><creatorcontrib>Ratini, Silvia</creatorcontrib><creatorcontrib>Castillo, Andres Del</creatorcontrib><creatorcontrib>Colleoni, Marco</creatorcontrib><creatorcontrib>Talakhadze, Nina</creatorcontrib><creatorcontrib>Rotmensz, Nicole</creatorcontrib><creatorcontrib>Viale, Giuseppe</creatorcontrib><creatorcontrib>Veronesi, Umberto</creatorcontrib><creatorcontrib>Luini, Alberto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gentilini, Oreste</au><au>Veronesi, Paolo</au><au>Botteri, Edoardo</au><au>Soggiu, Fiammetta</au><au>Trifirò, Giuseppe</au><au>Lissidini, Germana</au><au>Galimberti, Viviana</au><au>Musmeci, Simona</au><au>Raviele, Paola Rafaniello</au><au>Toesca, Antonio</au><au>Ratini, Silvia</au><au>Castillo, Andres Del</au><au>Colleoni, Marco</au><au>Talakhadze, Nina</au><au>Rotmensz, Nicole</au><au>Viale, Giuseppe</au><au>Veronesi, Umberto</au><au>Luini, Alberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2011-10-01</date><risdate>2011</risdate><volume>18</volume><issue>10</issue><spage>2879</spage><epage>2884</epage><pages>2879-2884</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Purpose
This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution.
Methods
Between June 1999 and December 2007, 337 patients with multicentric breast cancer and a clinically negative axilla underwent lymphatic mapping by a single periareolar/peritumoral (
n
= 306) or a double peritumoral or subdermal injection (
n
= 31) of
99m
Tc-HSA nanocolloids. The sentinel lymph node (SLN) was evaluated by intraoperative frozen section and axillary dissection was performed only in cases of positive SLNB.
Results
The median age of the patients was 48 (range, 22–81) years. The mean number of hot spots identified was 1.4 in the whole series, 1.3 in patients who received a single injection, and 1.7 in those who received a double injection (
P
< 0.001). The mean number of removed SLNs was 1.7 (median, 1; range, 1–7) with an identification rate of 100%. A total of 138 patients with negative SLNB (
n
= 134) or isolated tumor cells in the SLN (
n
= 4) did not receive completion axillary lymph node dissection (CALND). In these latter patients, a total of 27 events (19.5%) occurred with 3 patients (2.2%) developing axillary recurrences after a median follow-up of 5 years (range, 17–134 months).
Conclusions
Axillary lymph node reappearance was infrequent among patients with multicentric breast cancer, having negative SLNB and no CALND. We recommend SLNB as the standard procedure for nodal staging in patients with multicentric breast cancer and a clinically negative axilla.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>21479691</pmid><doi>10.1245/s10434-011-1694-3</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1068-9265 |
| ispartof | Annals of surgical oncology, 2011-10, Vol.18 (10), p.2879-2884 |
| issn | 1068-9265 1534-4681 |
| language | eng |
| recordid | cdi_proquest_journals_888706605 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Adult Aged Aged, 80 and over Axilla Breast Neoplasms - mortality Breast Neoplasms - pathology Breast Neoplasms - surgery Breast Oncology Carcinoma, Ductal, Breast - mortality Carcinoma, Ductal, Breast - secondary Carcinoma, Ductal, Breast - surgery Carcinoma, Lobular - mortality Carcinoma, Lobular - secondary Carcinoma, Lobular - surgery Female Follow-Up Studies Humans Medicine Medicine & Public Health Middle Aged Neoplasm Invasiveness Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - surgery Neoplasm Staging Oncology Prognosis Retrospective Studies Sentinel Lymph Node Biopsy Surgery Surgical Oncology Survival Rate Young Adult |
| title | Sentinel Lymph Node Biopsy in Multicentric Breast Cancer: Five-Year Results in a Large Series from a Single Institution |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A33%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sentinel%20Lymph%20Node%20Biopsy%20in%20Multicentric%20Breast%20Cancer:%20Five-Year%20Results%20in%20a%20Large%20Series%20from%20a%20Single%20Institution&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Gentilini,%20Oreste&rft.date=2011-10-01&rft.volume=18&rft.issue=10&rft.spage=2879&rft.epage=2884&rft.pages=2879-2884&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-011-1694-3&rft_dat=%3Cproquest_cross%3E2449661071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=888706605&rft_id=info:pmid/21479691&rfr_iscdi=true |